लोड हो रहा है...
Riociguat for the treatment of transthyretin cardiac amyloidosis: data from a named patient use program in Austria
Patients with transthyretin cardiac amyloidosis (TTR CA) suffer from impaired exercise capacity, have a poor quality of life (QoL), and approved treatments are lacking. Stimulators of the soluble guanylate cyclase are promising new pharmaceuticals in the treatment armamentarium of heart failure pati...
में बचाया:
| में प्रकाशित: | Pulm Circ |
|---|---|
| मुख्य लेखकों: | , , , , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
SAGE Publications
2019
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6886277/ https://ncbi.nlm.nih.gov/pubmed/31007127 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045894019849394 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|